The manuscript, "Design, development and randomized control trial of app "QinTB" on smoking cessation for tuberculosis patients: Study protocol" described an innovative trial to use theories of behavior change and knowledge of Chinese culture to develop a mobile app to help a high-risk group of smokers quit -those with tuberculosis (TB). The inclusion of objective to examine moderators of the app effects and to examine the impact on TB outcomes will increase the impact of these findings. While this protocol seems promising, there were many parts of the manuscript that were unclear and important design features were missing.
On p. 9 the authors suggest that a behavioral intervention will be conducted, but this behavioral intervention is never specified. If the authors are referring to the use of the app, this needs to be clarified. It is also unclear what is meant by "adjust smoking behaviors' threat and coping appraisal."
The use of the two theories is interesting, especially as it makes the app relevant for all smokers, regardless of their interest in quitting. However, very little detail is provided regarding how these theories will be adapted to actual app functions. Table 1 would benefit from an inclusion of a few examples of how the app will do the things described in the Description column. The flow in Figure 1 also doesn't illustrate any incorporation of the theory-based intervention components.
It does not appear that the app will be tailored to TB disease state. It would be helpful to provide some examples of any such tailoring, if it is going to occur. If it will not be tailored to TB disease state, it would be helpful to provide a rationale for testing this app among TB patients.
There is a discussion on p. 11 that the app will permit use of video and audio features, but that is never discussed in the manuscript. Such features would be very interesting. No rationale is given for why participants have to be smoking for at least 5 years before they are offered help quitting.
It was unclear why FTND was the only stratification factor used for randomization. Gender it typically used in treatment studies.
Are participants only compensated for completing the baseline assessment?
On the top of p. 13 the authors state that all participants can use the app. If this is correct, then what differentiates the two treatment conditions?
It is unclear whether participants in the doctor's advice group are actually getting their advice from a physician or research staff. Is the research staff providing this intervention a physician? Also, it is unclear whether any of the ABCs described for the advice group will also be given to the app group when they meet with study staff. No rationale is given for why these patients are not being given smoking cessation pharmacotherapy. This is considered appropriate clinical practice in the U.S. and so it is surprising that it is not offered as part of good clinical practice in this trial.
The manuscript would benefit from editing by a native English speaker.
VERSION 1 -AUTHOR RESPONSE
Respond to reviewer comments  The definition of the primary outcome is confusing. The authors suggest it is 6 months sustained abstinence, but note that they will allow smoking of up to 5 cigarettes during that time. This is not necessarily a problem, but it would be clearer if they were to note that it is not sustained abstinence, but rather sustained abstinence that allows 5 slips. In addition, carbon monoxide assessment at 6 months does not biochemically verify such extended abstinence, due to the short half-life of carbon monoxide.  Respond: Thank you for your suggestion. We make a clearer description of our primary outcome in "Primary and Secondary outcome" section.
 Please clarify whether participants missing cessation outcome data in the ITT analyses will be considered smoking. Respond: Thank you for your suggestion. We add a clarification "Participants who were lost to followup or did not provide cessation outcome data were classified as not being abstinent in the analysis" in "Statistical analysis" section.
 The authors claim that a homogenous group of patients reduces bias. However, it also significantly limits the generalizability of these findings. Please provide a rationale for why such a homogeneous sample is needed and who is being excluded to make this sample so homogeneous. The current inclusion/exclusion criteria do not suggest that this is an especially restricted sample.  Respond: Thank you for your suggestion. We delete the description regarding this part.
 The authors plan to examine health awareness, threat appraisal, coping appraisal, and protection motivation. However, these are not all included in Table 2 and it is unclear how these constructs are defined and how they will be measured. Respond: Thanks for your suggestion. We include these outcomes in Table 2 , and make a clarification of the definition and measuring method of these outcomes in the section of Step 1 Design and development of the smartphone App "QinTB".
 On p. 9 the authors suggest that a behavioral intervention will be conducted, but this behavioral intervention is never specified. If the authors are referring to the use of the app, this needs to be clarified. It is also unclear what is meant by "adjust smoking behaviors' threat and coping appraisal." Respond: Thanks for your comment. We re-create the Figure 1 and add example in Table 1 to explain how TTM and PMT will be adapted to actual app functions. We also explained how to adjust smoking behaviors' threat and coping appraisal in the third paragraph of Step 1 Design and development of the smartphone App "QinTB"  The use of the two theories is interesting, especially as it makes the app relevant for all smokers, regardless of their interest in quitting. However, very little detail is provided regarding how these theories will be adapted to actual app functions. Table 1 would benefit from an inclusion of a few examples of how the app will do the things described in the Description column. The flow in Figure 1 also doesn't illustrate any incorporation of the theory-based intervention components. Respond: Thank you for your suggestion. We re-create the Figure 1 and add example in Table 1 to explain how TTM and PMT will be adapted to actual app functions.
 It does not appear that the app will be tailored to TB disease state. It would be helpful to provide some examples of any such tailoring, if it is going to occur. If it will not be tailored to TB disease state, it would be helpful to provide a rationale for testing this app among TB patients. Respond: Thank you for your suggestion. We have written in APP group section, This app will record TB disease states as an part of patient's information, and also provide knowledge regarding harms of smoking on TB as an intervention content. Those intervention information will designed according to patients TB status, thus make it relevant with different patients.
 There is a discussion on p. 11 that the app will permit use of video and audio features, but that is never discussed in the manuscript. Such features would be very interesting. Respond: Thank you for your suggestion. In fact, our novelty is to send personalized video and audio when smoker's intention-to-quit stage is evaluated. For example, for smokers at pre-contemplation, we will send video and audio which introduce the dangers of smoking, while for smokers at preparation, we will send video and audio which encourage them to do so.
 No rationale is given for why participants have to be smoking for at least 5 years before they are offered help quitting. Respond: Thank you for your suggestion. We require participants to be smoking for at least 5 years to exclude new smokers which are more likely to quit. This is also used in other researches  It was unclear why FTND was the only stratification factor used for randomization. Gender it typically used in treatment studies. Respond: Thank you for your suggestion. Given the high prevalence of smoking in China, we believe the majority of our participants would be male, therefore gender is not taken as a stratification factor.
 Are participants only compensated for completing the baseline assessment? Respond: Thank you for your suggestion. After completing the entire study, participants will be given another gift card valued at $20. We add this clarification in the manuscript.
 On the top of p. 13 the authors state that all participants can use the app. If this is correct, then what differentiates the two treatment conditions? Respond: Thank you for your suggestion. App is only used in app group. We add a clear clarification in the manuscript.
 It is unclear whether participants in the doctor's advice group are actually getting their advice from a physician or research staff. Is the research staff providing this intervention a physician? Also, it is unclear whether any of the ABCs described for the advice group will also be given to the app group when they meet with study staff. Respond: Thank you for your suggestion. The participants in the doctor's advice group are getting their advice from physicians. In addition, to minimize the confounding effects of physicians-patient communication, the interview in app group will be less than 10 min, and the words used during physicians-patient communication will be more neutral. We add these clarifications in the manuscript.
 No rationale is given for why these patients are not being given smoking cessation pharmacotherapy. This is considered appropriate clinical practice in the U.S. and so it is surprising that it is not offered as part of good clinical practice in this trial. Respond: Thank you for your suggestion. In our opinion, the effects of pharmacotherapy will probably mask the effects of our app, so we could not evaluate its efficacy. Therefore smoking cessation pharmacotherapy is not given.
 The manuscript would benefit from editing by a native English speaker. Respond: Thank you for your suggestion. We improve our English writing and correct several mistakes of English grammar, punctuation and spelling in the Manuscript.
VERSION 2 -REVIEW

REVIEWER
Megan Piper University of Wisconsin, Madison, USA REVIEW RETURNED 06-Sep-2019
GENERAL COMMENTS
The authors were very responsive to the prior reviews and I believe the paper is much clearer. However, there are still small areas of confusion in the paper that would be helpful to address.
The authors use the phrase, "the anti-tuberculosis treatment spillover effect" in the Abstract and on p. 5. I am not sure what this means.
The landmark Surgeon General's report was the 1964 report, not the 2014 report. I would suggest simply stating that the "2014 Surgeon General's report…".
The manuscript still requires strong copy editing. There are a number of grammatical errors and sentences that appear to have missing words. On p. 5 there are 2: "Application-based interventions ARE cost effective and can proactively reach out TO smokers." "…content and theory used in THE development process is not clear that researchers cannot take advantage of previous experiences…" The meaning of this clause is unclear.
In Figure 1 it is unclear how the baseline assessment differs from the box that contains demographic information, TB disease status and smoking history. Are these the variables that are assessed at the baseline assessment?
The authors provided a rationale for only including smokers who have been smoking for 5 or more years in their response to reviewers letter, but not in the manuscript itself. I think it would be helpful to the reader to include the rationale in the paper, including the references mentioned in the letter.
The exclusion criteria: "with other severe diseases that cannot follow doctors advice" is unclear as is the definition of "unable to finish the study". If this is an intent-to-treat study, participants don't have to complete the study.
The authors raised an excellent point that they anticipate that the vast majority of smokers in China are men and therefore they are not blocking by gender. If the authors are confident that they will only recruit men, this is fine. However, if there are a small number of women then blocking on gender is even more important to make sure there is an even distribution of women across the 2 conditions. It is unclear why nicotine dependence will be assessed daily. Typically this construct does not change on a daily basis.
It is unclear how many text messages, videos and audio messages will be sent once participants set their quit day.
In the assessment of app utilization it is unclear what "preference" refers to. Does this mean participants' liking of different components of the app?
It is unclear what the proposed abstinence rates of 35% and 50% are based on. These seem to be very high rates for an app that is used by all smokers, including those that do not want to quit when they enter the study.
The phrase "homogeneity of subjects" is inaccurate. The authors are confirming that the randomization procedures worked and that they have similar samples in both treatment groups.
The authors indicate that they will assess group differences in the utilization of the app. However, only one group will have access to the app so there will be clear group differences based on the randomly assigned study group.
It is unclear why willingness to quit is only assessed at baseline. Based on the description of the app interventions, it appears that one of the key goals is to increase motivation to quit. This would seem to be a key outcome variable.
One more substantive concern is whether the app is focused on getting smokers to make a quit attempt or whether it is also providing a cessation intervention. In Figure 1 it appears that the PMT-based interventions are involved in developing a quit plan. The follow-up assessments are based on time since a quit date, but if most participants don't set a quit date, then none of these assessments will be completed. Also, the final outcome is 6 months post-target quit day. However, there it is likely that the majority of smokers won't set a quit day and it is possible that this quit day could occur at any time. Given that the focus of the app is on getting smokers to be willing to make a quit attempt, a more proximal primary outcome might be making an actual quit attempt that lasts at least 24 hours.
VERSION 2 -AUTHOR RESPONSE
Reviewer(s)' Comments to Author:  The authors use the phrase, "the anti-tuberculosis treatment spillover effect" in the Abstract and on p. 5. I am not sure what this means. Respond: Thank you for your comment. Consequently, we have changed the sentence in abstract from "However, there are few effective applications that could support TB patients to extend the antituberculosis treatment spillover effect for smoking cessation." to "However, there are few effective applications that could support TB patients to quit smoking". In addition, we have changed the sentence in Page 5 from "Currently, there is neither high-quality evidence nor effective applications of smoking cessation in the market that could support TB patients to extend the anti-tuberculosis treatment spillover effect for smoking cessation during this 'teachable moment' " to "Currently, there is neither high-quality evidence nor effective applications of smoking cessation in the market that could support TB patients to quit smoking during this 'teachable moment' "  The landmark Surgeon General's report was the 1964 report, not the 2014 report. I would suggest simply stating that the "2014 Surgeon General's report…". Respond: Thank you for your comment. We consequently changed our writing.
 The manuscript still requires strong copy editing. There are a number of grammatical errors and sentences that appear to have missing words. On p. 5 there are 2: "Application-based interventions ARE cost effective and can proactively reach out TO smokers." "…content and theory used in THE development process is not clear that researchers cannot take advantage of previous experiences…" The meaning of this clause is unclear.
Respond: Thank you for your comment. We further improve our English writing and correct several mistakes of English grammar, punctuation and spelling in the Manuscript.
 In Figure 1 it is unclear how the baseline assessment differs from the box that contains demographic information, TB disease status and smoking history. Are these the variables that are assessed at the baseline assessment? Respond: Thank you for your comment. Yes, these the variables are assessed at the baseline assessment. In fact, the baseline assessment in our study has overlap with baseline assessment in app. This is because if we delete the baseline assessment in app, our app could not record user's information, especially when this study is finished.
 The authors provided a rationale for only including smokers who have been smoking for 5 or more years in their response to reviewers letter, but not in the manuscript itself. I think it would be helpful to the reader to include the rationale in the paper, including the references mentioned in the letter. Respond: Thank you for your comment. We have added this explanation in the Manuscript.
 The exclusion criteria: "with other severe diseases that cannot follow doctors advice" is unclear as is the definition of "unable to finish the study". If this is an intent-to-treat study, participants don't have to complete the study. Respond: Thank you for your comment. We have deleted "with other severe diseases that cannot follow doctors advice". For "unable to finish the study", if a participant wants to join our study and meets all the inclusion criteria, but he is living very far from our study center and can not come on time, we will still not include him into our study because he "unable to finish the study". It has nothing to do with intent-to-treat.
 The authors raised an excellent point that they anticipate that the vast majority of smokers in China are men and therefore they are not blocking by gender. If the authors are confident that they will only recruit men, this is fine. However, if there are a small number of women then blocking on gender is even more important to make sure there is an even distribution of women across the 2 conditions. Respond: Thank you for your comment. Based on your suggestion, we will only recruit men for this study. We have changed in the Manuscript.
 Figure 2 does not add to what is already clearly described in the text. Respond: Thank you for your comment. We have deleted Figure 2 .
 It is unclear why nicotine dependence will be assessed daily. Typically this construct does not change on a daily basis. Respond: Thank you for your comment. We have deleted nicotine dependence from "From this moment, they will be instructed to report status every day, particularly their smoking status, TB medication compliance and nicotine dependence status" in Page 9. In addition, as show in Table 2 , nicotine dependence will be assessed 1 month, 2 month, 3 month, 4 month, 5 month and 6 month after quit date, not daily.
 It is unclear how many text messages, videos and audio messages will be sent once participants set their quit day. Respond: Thank you for your comment. Our plan is to send 3 to 5 messages per day, which is added in the Manuscript in Page 9.
 In the assessment of app utilization it is unclear what "preference" refers to. Does this mean participants' liking of different components of the app? Respond: Thank you for your comment. Yes, preference means participants' liking of different components of the app. We have added this explanation in the Manuscript in Page 11.
 It is unclear what the proposed abstinence rates of 35% and 50% are based on. These seem to be very high rates for an app that is used by all smokers, including those that do not want to quit when they enter the study. Respond: Thank you for your comment. Our estimated abstinence rate is relatively higher than some researches, such as reference 15 and 16, where the long-term abstinence rate is about 20%, but those participants are healthy people, not TB patients. For TB patients, studies showed they had significantly higher rate of success in quitting smoking (more than 50%), such as reference 9 and 11. Besides, we do not find any research that use app to help TB patients to quit. Taken together, we proposed the abstinence rate in our study is 50%.
 The phrase "homogeneity of subjects" is inaccurate. The authors are confirming that the randomization procedures worked and that they have similar samples in both treatment groups. Respond: Thank you for your comment. We deleted this expression.
 The authors indicate that they will assess group differences in the utilization of the app. However, only one group will have access to the app so there will be clear group differences based on the randomly assigned study group. Respond: Thank you for your comment. We deleted the "utilization of the app" in Page 12
 It is unclear why willingness to quit is only assessed at baseline. Based on the description of the app interventions, it appears that one of the key goals is to increase motivation to quit. This would seem to be a key outcome variable. Respond: Thank you for your comment. We should assess willingness to quit at every follow-up visit point. Therefore, we have edited Table 2 accordingly.
 One more substantive concern is whether the app is focused on getting smokers to make a quit attempt or whether it is also providing a cessation intervention. In Figure 1 it appears that the PMTbased interventions are involved in developing a quit plan. The follow-up assessments are based on time since a quit date, but if most participants don't set a quit date, then none of these assessments will be completed.  Respond: Thank you for your comment. Our hypothesis is this app could both help smokers to make a quit attempt and provide a cessation intervention. If participants don't set a quit date, we will consider them as "failed to quit".
 Also, the final outcome is 6 months post-target quit day. However, there it is likely that the majority of smokers won't set a quit day and it is possible that this quit day could occur at any time. Given that the focus of the app is on getting smokers to be willing to make a quit attempt, a more proximal primary outcome might be making an actual quit attempt that lasts at least 24 hours.  Respond: Thank you for your comment. We add making an actual quit attempt that lasts at least 24 hours as one of secondary outcomes. Again, we sincerely thank you for your comments. 
GENERAL COMMENTS
The authors have been very responsive in their revisions. I have no further concerns.
